scispace - formally typeset
D

Daniela S. S. Lobo

Researcher at Centre for Addiction and Mental Health

Publications -  34
Citations -  1163

Daniela S. S. Lobo is an academic researcher from Centre for Addiction and Mental Health. The author has contributed to research in topics: Major depressive disorder & Amphetamine. The author has an hindex of 16, co-authored 32 publications receiving 1048 citations. Previous affiliations of Daniela S. S. Lobo include University of São Paulo & University of Calgary.

Papers
More filters
Journal ArticleDOI

In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO.

TL;DR: The results are consistent with a hyperdopaminergic state in PG, and support the hypothesis that dopaminergic sensitization involving D3-related mechanisms might contribute to the pathophysiology of behavioral addictions.
Journal ArticleDOI

The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.

TL;DR: There appear to be no marked differences in D2 /D3 levels between healthy subjects and pathological gamblers, suggesting that low receptor availability may not be a necessary feature of addiction, but relationships between [11C]-PHNO binding and gambling severity/impulsiveness suggests involvement of the D3 receptor in impulsive/compulsive behaviours.
Journal ArticleDOI

Factors at play in faster progression for female pathological gamblers: An exploratory analysis

TL;DR: Two factors could be at play for treatment-seeking female gamblers in Brazil: a potential gender vulnerability and a cultural environment yielding them access to a narrower range of gambling games that includes mainly the most addictive ones.
Journal ArticleDOI

Genetic aspects of pathological gambling: a complex disorder with shared genetic vulnerabilities.

TL;DR: Findings from genetic studies conducted on pathological gambling corroborate further the importance of understanding the biological underpinnings of PG in the development of more specific treatment and prevention strategies.